HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Streptonigrin inhibits β-Catenin/Tcf signaling and shows cytotoxicity in β-catenin-activated cells.

AbstractBACKGROUND:
Activation of β-catenin/T-cell factor (Tcf) signaling plays a role in human carcinogenesis. This suggests a possibility that the β-catenin/Tcf signaling activated by the accumulation of β-catenin in the nucleus is related to some type of human carcinogenesis. Therefore, if β-catenin's transcriptional activity can be markedly down-regulated, tumor growth will be suppressed in β-catenin activated types of cancer.
METHODS:
To investigate the activation or suppression of β-catenin/Tcf transcription, we established a transiently transfected cell line with a constitutively active β-catenin mutant gene whose product is not degraded. This cell line was also co-transfected with luciferase reporter gene constructs containing either an optimized (TOPflash) or mutant (FOPflash) Tcf-binding element.
RESULTS:
We identified the inhibitory effect of streptonigrin against β-catenin/Tcf signaling in β-catenin activated cells. Streptonigrin inhibited the transcriptional activity of β-catenin/Tcf in SW480 cells and HEK293 cells transiently transfected with a constitutively active mutant β-catenin gene. The growth inhibitory effect of streptonigrin was more evident in β-catenin-activated cancer cells than in non-activated cancer cells. The electrophoresis mobility shift assay showed that the binding of Tcf complexes with their specific DNA-binding sites was suppressed by streptonigrin.
CONCLUSION:
Streptonigrin is a negative regulator of β-catenin/Tcf signaling, and their inhibitory mechanism is related to the proliferation inhibitory effect on β-catenin-activated cancer cells.
GENERAL SIGNIFICANCE:
This report reveals a molecular mechanism underlying the anti-tumor effect of streptonigrin from the perspective β-catenin/Tcf signaling. Given its function in inhibiting β-catenin/Tcf signaling, streptonigrin may be of interest as a leading compound for chemotherapeutic agent against β-catenin-activated tumorigenesis.
AuthorsSeyeon Park, Sohyun Chun
JournalBiochimica et biophysica acta (Biochim Biophys Acta) Vol. 1810 Issue 12 Pg. 1340-5 (Dec 2011) ISSN: 0006-3002 [Print] Netherlands
PMID21763403 (Publication Type: Journal Article)
Copyright2011 Elsevier B.V. All rights reserved.
Chemical References
  • DNA Primers
  • TCF Transcription Factors
  • beta Catenin
  • Streptonigrin
Topics
  • Base Sequence
  • Blotting, Western
  • Cell Line
  • Cell Proliferation (drug effects)
  • DNA Primers
  • Electrophoretic Mobility Shift Assay
  • Humans
  • Real-Time Polymerase Chain Reaction
  • Signal Transduction (drug effects)
  • Streptonigrin (pharmacology)
  • TCF Transcription Factors (metabolism)
  • beta Catenin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: